ArticleJAMA network open2025
Formulary Restrictions and Relapse Episodes in Persons With Relapsing-Remitting Multiple Sclerosis.
Barbara Blaylock et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it